Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they'd stumbled upon a revolutionary tool researchers could ...

CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells.

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

By leveraging the Protein Mutation Effect Predictor (ProMEP), AI-AncBE4max, a high-performance Cas9 variant with eight ...

CRISPR Therapeutics AG (NASDAQ:CRSP) in Cathie Wood's Stock Portfolio is one of the top 10 stocks to buy now. On August 7, analysts at H.C. Wainwright reiterated a ‘Buy’ rating on the stock and raised ...

CRISPR: Is The Selloff Really Over? I guess that's what biotech investors should be familiar with, as the stock of CRISPR Therapeutics AG (CRSP) has truly undergone a roller coaster ride all year, ...